← Back to Clinical Trials
Recruiting NCT07296133

NCT07296133 GAMES Intervention in MCI (Mild Cognitive Impairment)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07296133
Status Recruiting
Phase
Sponsor Emory University
Condition Mild Cognitive Impairment
Study Type INTERVENTIONAL
Enrollment 124 participants
Start Date 2025-12-08
Primary Completion 2027-03

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
Online Gameplay InterventionWaitlist control

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 124 participants in total. It began in 2025-12-08 with a primary completion date of 2027-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objective of the present study is to evaluate whether online, remote gameplay can facilitate social engagement and reduce feelings of loneliness and isolation in adults with and without mild cognitive impairment (MCI).

Eligibility Criteria

Inclusion Criteria: * 50 to 85 years old * Living independently (note: can live in assisted living, but must have independently complete daily activities) * Fluent in English * Adequate visual and auditory acuity to see/hear computer screen * MoCA-Blind (converted to MoCA score) \> 17 Additional Criteria for MCI Group: * Existing diagnosis by HC professional * MoCA-Blind (converted to MoCA score) of 18-25 * FAQ \< 9 Exclusion Criteria: * Cognitive impairment secondary to stroke, TBI or other neurological cause without concern for neurodegenerative condition (e.g., Alzheimer's disease, vascular dementia, etc.) * Medical illnesses that would prevent participation * Major psychiatric disturbance meeting DSM V criteria in last year * Hx of substance abuse within last two years * Current psychoactive med use

Contact & Investigator

Central Contact

Kayci Vickers, PhD

✉ kayci.lynne.vickers@emory.edu

📞 (404) 712-4849

Principal Investigator

Kayci Vickers, PhD

PRINCIPAL INVESTIGATOR

Emory University

Frequently Asked Questions

Who can join the NCT07296133 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, up to 85 Years, studying Mild Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07296133 currently recruiting?

Yes, NCT07296133 is actively recruiting participants. Contact the research team at kayci.lynne.vickers@emory.edu for enrollment information.

Where is the NCT07296133 trial being conducted?

This trial is being conducted at Atlanta, United States.

Who is sponsoring the NCT07296133 clinical trial?

NCT07296133 is sponsored by Emory University. The principal investigator is Kayci Vickers, PhD at Emory University. The trial plans to enroll 124 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology